0.25Open0.55Pre Close7 Volume73 Open Interest75.00Strike Price194.00Turnover48.96%IV6.19%PremiumDec 6, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.30Extrinsic Value100Contract SizeAmericanOptions Type-0.1196Delta0.0480Gamma289.56Leverage Ratio-0.0962Theta-0.0010Rho-34.64Eff Leverage0.0169Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet